GO:0010826 negative regulation of centrosome duplication: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010826 describes any process that decreases the frequency, rate or extent of centrosome duplication, the replication of a centrosome from which the microtubule spindle apparatus is organized.
• Negative regulators of centrosome duplication include BRCA1, Sufu, Nek2, deacetylases, casein kinase II and ZYG-1, which act at distinct steps of the centrosome duplication cycle.
• Loss of negative regulation causes centrosome amplification, a hallmark of many cancers and a driver of aneuploidy.
• The process is coordinated with the DNA damage response and cell cycle checkpoints, ensuring that centrosomes duplicate once and only once per cell cycle.
• Post-translational modifications such as phosphorylation, acetylation and deacetylation control the stability and activity of centrosome duplication regulators.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal dissection of negative regulators in human cells and model organisms.
Description
Centrosome duplication is the process by which a cell replicates its centrosome, a structure composed of a pair of centrioles and peri-centriolar material that organizes the microtubule spindle apparatus. To maintain genomic stability, this process must occur exactly once per cell cycle, and negative regulation of centrosome duplication (GO:0010826) encompasses all molecular mechanisms that decrease the frequency, rate or extent of this event. Disruption of these brakes leads to centrosome amplification, multipolar spindles and aneuploidy, which are frequently observed in cancer and other proliferative disorders. Research over the past two decades has identified a diverse set of negative regulators, including BRCA1, Sufu, Nek2, histone deacetylases, casein kinase II and the C. elegans kinase ZYG-1. These proteins act at different steps of the centrosome duplication cycle, from licensing and initiation to elongation and separation, and are often controlled by cell cycle-dependent post-translational modifications. Understanding how these factors cooperate is essential for deciphering the molecular basis of centrosome homeostasis and for developing therapeutic strategies that target centrosome amplification in disease. This article integrates authoritative QuickGO annotation for GO:0010826 with verified PubMed literature to provide a research-grade overview of the negative regulation of centrosome duplication, its key genes, regulatory mechanisms, disease relevance and experimental models. It is intended for researchers who need a concise, citable resource for study design, grant writing and CRISPR-based functional genomics.
negative regulation of centrosome duplication At A Glance
| GO ID | GO:0010826 |
|---|---|
| GO term | negative regulation of centrosome duplication |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the frequency, rate or extent of centrosome duplication, thereby preventing centrosome amplification and maintaining genomic stability. |
| Key regulators | BRCA1, Sufu, Nek2, histone deacetylases, casein kinase II, ZYG-1. |
| Associated cellular structure | Centrosome, composed of a pair of centrioles and peri-centriolar material. |
| Disease relevance | Loss of negative regulation is linked to centrosome amplification, aneuploidy and cancer. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, proximity interactomics, live-cell imaging. |
What Is GO:0010826?
GO:0010826 (negative regulation of centrosome duplication) is a biological process term defined as any process that decreases the frequency, rate or extent of centrosome duplication. Centrosome duplication itself is the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized. In practical terms, this GO term covers molecular events that put the brakes on centrosome duplication, ensuring that cells do not over-duplicate their centrosomes and thereby maintain genomic stability.
Why Is negative regulation of centrosome duplication Important in Cell Biology?
Negative regulation of centrosome duplication is critical because it ensures that centrosomes duplicate exactly once per cell cycle, a prerequisite for bipolar spindle assembly and accurate chromosome segregation. When this regulation fails, cells accumulate extra centrosomes, leading to multipolar spindles, aneuploidy and tumorigenesis. Moreover, negative regulators such as BRCA1 and Sufu connect centrosome duplication to the DNA damage response and developmental signaling, highlighting the broad physiological importance of this process.
• Prevents centrosome amplification, a hallmark of many solid tumors and hematological malignancies.
• Maintains genomic stability by ensuring bipolar spindle formation and accurate chromosome segregation.
• Coordinates centrosome duplication with the DNA damage response and cell cycle checkpoints.
• Provides mechanistic insights into aneuploidy, a common feature of cancer cells.
• Links developmental signaling pathways, such as Hedgehog signaling via Sufu, to centrosome homeostasis.
• Offers potential therapeutic targets for cancers with centrosome amplification.
• Serves as a paradigm for studying post-translational control of organelle duplication.
• Enables functional genomics studies using CRISPR screens and proximity interactomics.
• Relevant to inherited cancer predisposition syndromes involving BRCA1 mutations.
• Informs research on ciliopathies and developmental disorders linked to centrosome dysfunction.
What Happens During negative regulation of centrosome duplication?
Licensing and initiation control
In simple terms: Before a centrosome can duplicate, the cell must give it a license, and negative regulators can block or delay this license.
Centrosome duplication begins with the licensing of the mother centriole, a step that is tightly controlled to prevent re-duplication within the same cell cycle. Negative regulators such as BRCA1 act during this early phase to suppress unscheduled initiation, and loss of BRCA1 leads to centrosome amplification. In C. elegans embryos, casein kinase II negatively regulates centrosome duplication by controlling the initiation step, and its inhibition results in extra centrosomes. Similarly, Sufu negatively regulates both the initiation of centrosome duplication and DNA replication, coupling these two processes.
Elongation and maturation checkpoints
In simple terms: After initiation, the centrosome must grow and mature, and negative regulators can pause or slow this growth.
Following initiation, the procentriole elongates and the centrosome matures, processes that are subject to negative regulation. Proximity interactomics has identified regulators of centriole duplication, including proteins that restrain elongation. Deacetylases suppress centrosome duplication and amplification, indicating that histone deacetylase activity provides a negative brake during maturation. Nek2, a kinase involved in centrosome separation, also influences duplication fidelity, and its dysregulation promotes aneuploidy in breast cancer cells.
Coordination with the DNA damage response
In simple terms: When DNA is damaged, the cell can pause centrosome duplication to avoid making mistakes.
The DNA damage response proteins differentially regulate centrosome integrity, and some act as negative regulators of centrosome duplication under genotoxic stress. This coordination ensures that cells with damaged DNA do not duplicate centrosomes prematurely, which would exacerbate genomic instability. BRCA1, a central DNA damage response protein, also functions as a negative regulator of centrosome duplication, linking these two pathways.
Post-translational control of regulator stability
In simple terms: Chemical tags on proteins can make negative regulators more or less stable, thereby tuning the brake on centrosome duplication.
Site-specific phosphorylation of ZYG-1 regulates its stability and centrosome number, demonstrating that post-translational modifications directly control the abundance of a key duplication regulator. Casein kinase II phosphorylates substrates to negatively regulate centrosome duplication in C. elegans embryos. Deacetylases remove acetyl groups from target proteins to suppress centrosome duplication and amplification. These modifications provide reversible and rapid control over centrosome number.
Mitotic exit and resetting the brake
In simple terms: After cell division, the brake must be reset so the next cycle can start correctly.
Negative regulation must be relieved at the appropriate time to allow the next round of duplication in the subsequent cell cycle. Failure to reset these brakes can lead to centrosome amplification in the following cycle. The interplay between kinases such as Nek2 and phosphatases ensures that centrosome duplication is licensed only once per cycle. This temporal control is essential for maintaining centrosome number homeostasis across generations.
Key Genes Involved in GO:0010826 negative regulation of centrosome duplication
The following genes and proteins have been experimentally implicated in the negative regulation of centrosome duplication, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BRCA1 | Negative regulator of centrosome duplication; links DNA damage response to centrosome control | Breast and ovarian cancer; centrosome amplification in BRCA1-deficient cells |
| Sufu | Negatively regulates initiation of centrosome duplication and DNA replication | Hedgehog signaling; developmental disorders and cancer |
| Nek2 | Kinase involved in centrosome separation; dysregulation promotes aneuploidy | Breast cancer; centrosome amplification and aneuploidy |
| HDACs (histone deacetylases) | Suppress centrosome duplication and amplification | Cancer; epigenetic regulation of centrosome number |
| Casein kinase II | Negative regulator of centrosome duplication in C. elegans embryos | Model organism studies of cell division and centrosome control |
| ZYG-1 | Phosphorylation regulates stability and centrosome number | C. elegans embryo; centrosome duplication control |
| PLK4 | Master regulator of centriole duplication; subject to negative regulation | Centriole duplication; cancer and developmental disorders |
| STIL | Centriole duplication factor; interacts with regulators | Centrosome amplification; cancer |
| CPAP (CENPJ) | Centriole elongation factor; regulated by negative signals | Microcephaly and cancer |
| SAS-6 | Cartwheel component; regulated during duplication | Centriole assembly; model organisms |
| CEP152 | Centriole duplication protein; proximity interactor | Seckel syndrome and microcephaly |
| CEP192 | Centrosome maturation factor; regulated by negative signals | Centrosome maturation; cancer |
| Aurora A | Kinase that promotes centrosome maturation; counteracted by negative regulators | Cancer; mitotic fidelity |
| CDK2 | Cell cycle kinase; activity is restrained by negative regulators | Cell cycle control; centrosome duplication |
| ATM/ATR | DNA damage response kinases; coordinate with negative regulation | Genomic stability; cancer predisposition |
| CHK1 | Checkpoint kinase; influences centrosome integrity | DNA damage response; centrosome regulation |
| MCPH1 | Microcephaly protein; linked to centrosome regulation | Microcephaly; genomic stability |
How Is negative regulation of centrosome duplication Regulated?
Negative regulation of centrosome duplication is itself regulated at multiple levels. Cell cycle-dependent kinases such as CDK2 and Aurora A promote duplication, while negative regulators including BRCA1, Sufu and casein kinase II counteract these activities. Post-translational modifications, including phosphorylation by casein kinase II and ZYG-1 site-specific phosphorylation, control the stability and activity of key regulators. Deacetylation by histone deacetylases provides an additional layer of negative control. The DNA damage response kinases ATM, ATR and CHK1 coordinate with these regulators to pause duplication under genotoxic stress. Together, these mechanisms ensure that centrosome duplication occurs once and only once per cell cycle.
negative regulation of centrosome duplication and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Breast and ovarian cancer; centrosome amplification | BRCA1 knockout human cell lines; CRISPR KO in MCF10A |
| Nek2 | Breast cancer; aneuploidy | Nek2 overexpression or knockout in breast cancer cells |
| Sufu | Hedgehog signaling; developmental disorders | Sufu knockout mouse models or human cell lines |
| HDACs | Cancer; epigenetic regulation of centrosome number | HDAC inhibitor treatment in cancer cell lines |
| CPAP (CENPJ) | Microcephaly; centrosome dysfunction | CPAP point-mutation knock-in in human cells |
Cancer and centrosome amplification
Loss of negative regulation of centrosome duplication leads to centrosome amplification, a common feature of many cancers. BRCA1 deficiency causes centrosome amplification, contributing to genomic instability in breast and ovarian cancers. Nek2 dysregulation promotes aneuploidy in breast cancer cells, further linking negative regulation to tumorigenesis. Deacetylase suppression of centrosome duplication suggests that epigenetic drugs may affect centrosome number in cancer cells.
Developmental disorders and microcephaly
Mutations in centrosome-related genes such as CPAP (CENPJ), CEP152 and MCPH1 cause microcephaly and other developmental disorders. These proteins are subject to negative regulation during centrosome duplication, and their dysfunction disrupts the balance between duplication and restraint. Sufu, a negative regulator of centrosome duplication initiation, is also linked to Hedgehog signaling and developmental syndromes.
Aneuploidy and genomic instability
Defective negative regulation of centrosome duplication results in extra centrosomes, multipolar spindles and aneuploidy. Aneuploidy is a hallmark of cancer and is associated with poor prognosis. The DNA damage response proteins ATM, ATR and CHK1 help coordinate centrosome integrity with genomic stability, and their dysfunction can exacerbate aneuploidy.
From negative regulation of centrosome duplication-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene cause centrosome amplification? | CRISPR knockout in human cell lines (e.g., HeLa, MCF10A) |
| Does a specific phosphorylation site regulate protein stability? | Point-mutation knock-in of phospho-deficient or phospho-mimetic residues |
| Does a disease-associated mutation affect centrosome duplication? | Knock-in of patient-derived mutations in human cells |
| Where does a regulator localize during the cell cycle? | Tagged knock-in with fluorescent protein (e.g., GFP) |
| Does overexpression of a regulator suppress centrosome amplification? | Inducible overexpression in cancer cell lines |
| Which proteins interact with a negative regulator? | Proximity-dependent biotinylation (BioID) or APEX in cells |
How to Study the negative regulation of centrosome duplication Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Centrosome number and duplication timing | Monitoring effects of negative regulators in real time |
| Proximity interactomics (BioID) | Protein-protein interactions at centrosomes | Identifying regulators of centriole duplication |
| CRISPR knockout screens | Gene function in centrosome duplication | Discovering negative regulators |
| Phosphoproteomics | Site-specific phosphorylation | Mapping post-translational control of regulators |
| Immunofluorescence | Centrosome amplification and spindle morphology | Assessing aneuploidy and multipolar spindles |
| Western blot | Protein stability and expression | Validating knockout or overexpression |
| Flow cytometry | Cell cycle profile and DNA content | Linking centrosome defects to cell cycle |
| RNA-seq | Transcriptional changes | Identifying downstream pathways |
Live-cell imaging of centrosome duplication
Live-cell imaging using fluorescently tagged centriolar markers (e.g., Centrin1-GFP, CEP192-GFP) allows real-time monitoring of centrosome duplication and the effects of negative regulators. This method can quantify duplication frequency, timing and centrosome number in single cells.
Proximity interactomics
Proximity-dependent biotinylation (BioID) and related techniques identify interaction networks among centrosome components, revealing regulators of centriole duplication. This approach has been used to discover negative regulators and to map the centrosome interactome.
CRISPR-based functional genomics
CRISPR knockout and activation screens enable systematic identification of genes that negatively regulate centrosome duplication. These screens can be coupled with imaging-based readouts of centrosome number to discover novel regulators.
Phosphoproteomics and post-translational modification analysis
Mass spectrometry-based phosphoproteomics identifies site-specific phosphorylation events on centrosome regulators, such as ZYG-1, that control their stability and function. This method is useful for mapping signaling pathways that negatively regulate centrosome duplication.
How CRISPR Can Be Used to Study GO:0010826 negative regulation of centrosome duplication
Knockout
CRISPR knockout of negative regulators such as BRCA1, Sufu or Nek2 in human cell lines results in centrosome amplification, providing causal evidence for their role in GO:0010826. Knockout models are essential for validating candidate genes identified in screens.
Point Mutation
Point-mutation knock-in of phospho-deficient or phospho-mimetic residues in regulators like ZYG-1 allows dissection of site-specific phosphorylation that controls protein stability and centrosome number. This approach is also used to model disease-associated mutations in CPAP and other centrosome genes.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci enables live-cell imaging of centrosome dynamics and localization of negative regulators. Disease-relevant mutations can also be knocked in to study their impact on centrosome duplication.
Overexpression
Overexpression of negative regulators such as deacetylases or Sufu suppresses centrosome duplication and amplification, confirming their inhibitory function. Inducible overexpression systems allow temporal control of the brake on centrosome duplication.
How EDITGENE Supports negative regulation of centrosome duplication Research
Researchers studying negative regulation of centrosome duplication-related genes often need to determine whether a candidate gene is causally involved in restraining centrosome duplication or is merely correlated with the phenotype. This requires precise genetic models that can knockout, mutate, tag or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of centrosome duplication research.
Frequently Asked Questions About negative regulation of centrosome duplication
What is negative regulation of centrosome duplication (GO:0010826)?
It is any process that decreases the frequency, rate or extent of centrosome duplication, helping to prevent extra centrosomes and maintain genomic stability.
What genes are involved in negative regulation of centrosome duplication?
Key genes include BRCA1, Sufu, Nek2, histone deacetylases, casein kinase II and ZYG-1.
How does BRCA1 negatively regulate centrosome duplication?
BRCA1 acts as a negative regulator of centrosome duplication, and its loss leads to centrosome amplification, linking DNA damage response to centrosome control.
What happens when negative regulation of centrosome duplication fails?
Failure causes centrosome amplification, multipolar spindles and aneuploidy, which are common in cancer.
Which diseases are associated with defective negative regulation of centrosome duplication?
Cancer, microcephaly and developmental disorders are associated with defects in this process.
How is centrosome duplication negatively regulated during the cell cycle?
Cell cycle-dependent kinases promote duplication, while negative regulators such as BRCA1, Sufu and casein kinase II counteract them, often via phosphorylation and deacetylation.
What methods are used to study negative regulation of centrosome duplication?
Live-cell imaging, proximity interactomics, CRISPR screens, phosphoproteomics and immunofluorescence are commonly used.
Can CRISPR be used to study negative regulation of centrosome duplication?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are powerful tools to dissect gene function in this process.
What is the role of Sufu in centrosome duplication?
Sufu negatively regulates both the initiation of centrosome duplication and DNA replication.
How does Nek2 affect centrosome duplication?
Nek2 dysregulation promotes centrosome amplification and aneuploidy in breast cancer cells.
Conclusion
Negative regulation of centrosome duplication (GO:0010826) is a fundamental biological process that safeguards genomic stability by ensuring centrosomes duplicate only once per cell cycle. Its key regulators, including BRCA1, Sufu, Nek2, deacetylases, casein kinase II and ZYG-1, act at multiple steps and are controlled by post-translational modifications. Defects in this process lead to centrosome amplification, aneuploidy and diseases such as cancer and microcephaly. CRISPR-based models, combined with imaging, proteomics and screening approaches, provide powerful tools to dissect the molecular mechanisms of this process and to identify new therapeutic targets. EDITGENE offers comprehensive services to support these research efforts, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 1. Deng CX. 2002. Roles of BRCA1 in centrosome duplication.. Oncogene 21(40):6222-7 PMID: 12214252
- 2. Zhuang T et al.. 2021. Sufu negatively regulates both initiations of centrosome duplication and DNA replication.. Proc Natl Acad Sci U S A 118(28) PMID: 34260378
- 3. Firat-Karalar EN et al.. 2014. Proximity interactions among centrosome components identify regulators of centriole duplication.. Curr Biol 24(6):664-70 PMID: 24613305
- 4. Rai R et al.. 2008. Differential regulation of centrosome integrity by DNA damage response proteins.. Cell Cycle 7(14):2225-33 PMID: 18635967
- 5. Cappello P et al.. 2014. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.. Oncogene 33(18):2375-84 PMID: 23708664
- 6. Ling H et al.. 2012. Suppression of centrosome duplication and amplification by deacetylases.. Cell Cycle 11(20):3779-91 PMID: 23022877
- 7. Medley JC et al.. 2017. Casein kinase II is required for proper cell division and acts as a negative regulator of centrosome duplication in Caenorhabditis elegans embryos.. Biol Open 6(1):17-28 PMID: 27881437
- 8. Medley JC et al.. 2023. Site-specific phosphorylation of ZYG-1 regulates ZYG-1 stability and centrosome number.. iScience 26(12):108410 PMID: 38034351
